| Referências: |
NELSON, DAVID L.; COX, MICHAEL. Princípios de Bioquímica de Lehninger - 6ª Ed. 2014. AGARWAL, A. K. et al. AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nature Genetics, v. 31, n. 1, p. 21–23, 2002. AGARWAL, A. K. et al. Phenotypic and Genetic Heterogeneity in Congenital Generalized Lipodystrophy. The Journal of Clinical Endocrinology and Metabolism, v. 88, n. 10, p. 4840–4847, 2003. AGARWAL, A. K. A. K. et al. Seipin: A mysterious protein. Trends in Molecular Medicine, v. 10, n. 9, p. 440–444, 2004. AGARWAL, A. K.; GARG, A. Congenital generalized lipodystrophy: Significance of triglyceride biosynthetic pathways. Trends in Endocrinology and Metabolism, v. 14, n. 5, p. 214–221, 2003. AL-AUBAIDY, H. A.; JELINEK, H. F. Oxidative stress and triglycerides as predictors of subclinical atherosclerosis in prediabetes. Redox Report, v. 19, n. 2, p. 87–91, 2014. BI, J. et al. Seipin promotes adipose tissue fat storage through the ER Ca2+- ATPase SERCA. Cell Metabolism, v. 19, n. 5, p. 861–871, 2014. BINNS, D. et al. Seipin is a discrete homooligomer. Biochemistry, v. 49, p. 10747–10755, 2010. BODDU, N. J. et al. Is the lack of adiponectin associated with increased ER/SR stress and inflammation in the heart? Adipocyte, v. 3, n. 1, p. 10–18, 2014. GARG, A. Adipose Tissue Dysfunction in Obesity and Lipodystrophy. Abdominal Adiposity and Cardiometabolic Risk, v. 8, n. 4, p. 7–13, 2006. GARG, A. Lipodystrophies: Genetic and acquired body fat disorders. Journal of Clinical Endocrinology and Metabolism, v. 96, n. 11, p. 3313–3325, 2011. LIMA, J. G. et al. Clinical and laboratory data of a large series of patients with congenital generalized lipodystrophy. Diabetology & Metabolic Syndrome, v. 8, n. 23, p. 1–7, 2016. LIMA, J. G. et al. Causes of death in patients with Berardinelli-Seip congenital generalized lipodystrophy. PLoS ONE, v. 13, n. 6, p. 1–10, 2018. BROWN RJ, CHAIR C, ARAUJO-VILAR D, CHEUNG PT, DUNGER D, GARG A, et al. The diagnosis and management of lipodystrophy syndromes: A multi-society practice guideline. J Clin Endocrinol Metab. 2016;101: 4500–4511. doi:10.1210/jc.2016-2466 CRAVEIRO SARMENTO AS, MEDEIROS LB DE A, AGNEZ-LIMA LF, LIMA JG, DE MELO CAMPOS JTA, DE AZEVEDO MEDEIROS LB, et al. Exploring Seipin: From Biochemistry to Bioinformatics Predictions. Int J Cell Biol. 2018;2018: 1–21. doi:10.1155/2018/5207608 BADMAN MK, FLIER JS. The Adipocyte as an Active Participant in Energy Balance and Metabolism. Gastroenterology. 2007;132(6):2103-2115. doi:10.1053/j.gastro.2007.03.058. CHIQUETTE E, ORAL EA, GARG A, ARAÚJO-VILAR D, DHANKHAR P. Estimating the prevalence of generalized and partial lipodystrophy: Findings and challenges. Diabetes, Metab Syndr Obes Targets Ther. 2017. doi:10.2147/DMSO.S130810. GARG A, AGARWAL AK. Lipodystrophies: Disorders of adipose tissue biology. Biochim Biophys Acta - Mol Cell Biol Lipids. 2009;1791(6):507-513. doi:10.1016/j.bbalip.2008.12.014. VÁZQUEZ-VELA MEF, TORRES N, TOVAR AR. White Adipose Tissue as Endocrine Organ and Its Role in Obesity. Arch Med Res. 2008;39(8):715-728. doi:10.1016/j.arcmed.2008.09.005. PROENÇA AR, SERTIÉ RA, OLIVEIRA AC, CAMPAÑA AB, CAMINHOTTO RO, CHIMIN P, LIMA FB. New concepts in white adipose tissue physiology. Braz J Med Biol Res. 2014;47(3):192-205. CONDE J, SCOTECE M, GÓMEZ R, LÓPEZ V, GÓMEZ-REINO JJ, LAGO F, GUALILLO O. Adipokines: biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity. Biofactors. 2011;37(6):413-20. DE PAUW A, TEJERINA S, RAES M, KEIJER J, ARNOULD T. Mitochondrial (dys)function in adipocyte (de)differentiation and systemic metabolic alterations. Am J Pathol. 2009;175(3):927-39. YOUN BS, MIN SS, PARK KS, LEE HW, YU R, KWON BS. The role of adipocytokines in adipocyte-related pathological processes. Drug News Perspect. 2004;17(5):293-8. |
